4-Methyl-5-thiazoleethanol
| Common Name: |
4-Methyl-5-thiazoleethanol |
| IUPAC Name: |
2-(4-methyl-1,3-thiazol-5-yl)ethanol |
| Molecular Formula: |
C6H9NOS |
| SMILES: |
CC1=C(SC=N1)CCO |
| Inchi: |
1S/C6H9NOS/c1-5-6(2-3-8)9-4-7-5/h4,8H,2-3H2,1H3 |
| Inchi Key: |
BKAWJIRCKVUVED-UHFFFAOYSA-N |
| Cas No: |
137-00-8 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
3 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
143.21 |
| Mass (g/mol) |
143.04 |
| Molar Refractivity |
38.01 |
| Net Charge |
|
| HBD |
1 |
| HBA |
2 |
| Rt Bonds |
2 |
| Rings |
1 |
| TPSA |
61.36 |
| Hetero Atoms |
3 |
| Heavy Atoms |
9 |
| Aromatic Heavy Atoms |
5 |
| Melting Point (°C) |
<25 |
| Boiling Point (°C@760.00mm Hg) |
279.00 to 281.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.003 |
| Vapor Density (Air =1) |
4.9 |
| Fraction Csp3 |
0.50 |
| LogP |
0.986 |
| iLOGP |
1.65 |
| XLOGP3 |
0.85 |
| WLOGP |
0.99 |
| MLOGP |
-0.09 |
| ESOL Log S |
-1.54 |
| ESOL Solubility (mg/ml) |
4.11 |
| ESOL Solubility (mol/l) |
0.029 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.72 |
| Ali Solubility (mg/ml) |
2.72 |
| Ali Solubility (mol/l) |
0.02 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-1.89 |
| Silicos-IT Solubility (mg/ml) |
1.84 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.57 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.723 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.53 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
